DePuy Spine

Clinical trials sponsored by DePuy Spine, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

Medical device company specializing in spinal surgery products, part of Johnson & Johnson.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

New bone graft shows promise for neck surgery patients

Disease control Completed

This study looked at how well ViviGen, a bone graft made from donated human bone cells, helps fuse neck bones in people having 2- or 3-level neck surgery. 100 patients were followed to see if their bones fused and how their pain and function improved. The goal was to gather real-…

Sponsor: DePuy Spine • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC

DePuy Spine

New bone graft shows promise for neck surgery patients